‍

Blake, Wm. Genisis, object 2. 1827.

‍

Goldman Sachs predicts that the U.S. economy will grow faster as more Americans take Ozempic, a note from the bank this month reads. One analyst emphasized the GDP could increase by an additional 1% if 60 million Americans use the drug by 2028.

Studies show the weight-loss drug can reduce major cardiovascular events by 20%, boosting workforce participation and productivity. Healthcare costs could also be reduced.

Analyst: “Combining current losses in hours worked and labor force participation from sickness and disability, early deaths, and informal caregiving, we estimate that GDP would potentially be over 10% higher if poor health outcomes did not limit labor supply in the U.S.”